Dilan Özmen Özgün

518 total citations
9 papers, 464 citations indexed

About

Dilan Özmen Özgün is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Dilan Özmen Özgün has authored 9 papers receiving a total of 464 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Organic Chemistry, 4 papers in Molecular Biology and 3 papers in Pharmacology. Recurrent topics in Dilan Özmen Özgün's work include Synthesis and biological activity (3 papers), Enzyme function and inhibition (3 papers) and Cholinesterase and Neurodegenerative Diseases (3 papers). Dilan Özmen Özgün is often cited by papers focused on Synthesis and biological activity (3 papers), Enzyme function and inhibition (3 papers) and Cholinesterase and Neurodegenerative Diseases (3 papers). Dilan Özmen Özgün collaborates with scholars based in Türkiye, Japan and Italy. Dilan Özmen Özgün's co-authors include Halise İnci Gül, Cem Yamalı, Claudiu T. Supuran, İlhami Gülçın, Hiroshi Sakagami, Telat Yanık, Murat Şüküroğlu, Parham Taslımı, Andris Kazāks and Ja̅nis Leita̅ns and has published in prestigious journals such as Optical Materials, Bioorganic Chemistry and Journal of Enzyme Inhibition and Medicinal Chemistry.

In The Last Decade

Dilan Özmen Özgün

8 papers receiving 458 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dilan Özmen Özgün Türkiye 7 314 301 209 64 20 9 464
Kaan Küçükoğlu Türkiye 12 346 1.1× 348 1.2× 181 0.9× 36 0.6× 10 0.5× 31 541
Hüseyin Çavdar Türkiye 13 352 1.1× 292 1.0× 180 0.9× 42 0.7× 12 0.6× 17 562
Salih Ökten Türkiye 14 405 1.3× 281 0.9× 147 0.7× 70 1.1× 11 0.6× 49 565
Mehmet Abdullah Alagöz Türkiye 13 271 0.9× 139 0.5× 147 0.7× 106 1.7× 8 0.4× 46 441
Fakher Chabchoub Tunisia 16 499 1.6× 148 0.5× 289 1.4× 152 2.4× 11 0.6× 62 708
Halide Sedef Karaman Türkiye 12 359 1.1× 339 1.1× 246 1.2× 81 1.3× 5 0.3× 14 560
Sandip D. Firke India 7 237 0.8× 116 0.4× 110 0.5× 53 0.8× 25 1.3× 25 419
И. В. Серков Russia 12 319 1.0× 139 0.5× 298 1.4× 228 3.6× 15 0.8× 60 537
Mehtap Tugrak Türkiye 14 465 1.5× 480 1.6× 261 1.2× 49 0.8× 4 0.2× 24 664
Deniz S. Doğruer Türkiye 16 531 1.7× 180 0.6× 154 0.7× 113 1.8× 5 0.3× 36 663

Countries citing papers authored by Dilan Özmen Özgün

Since Specialization
Citations

This map shows the geographic impact of Dilan Özmen Özgün's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dilan Özmen Özgün with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dilan Özmen Özgün more than expected).

Fields of papers citing papers by Dilan Özmen Özgün

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dilan Özmen Özgün. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dilan Özmen Özgün. The network helps show where Dilan Özmen Özgün may publish in the future.

Co-authorship network of co-authors of Dilan Özmen Özgün

This figure shows the co-authorship network connecting the top 25 collaborators of Dilan Özmen Özgün. A scholar is included among the top collaborators of Dilan Özmen Özgün based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dilan Özmen Özgün. Dilan Özmen Özgün is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Uçar, Arzu, Dilan Özmen Özgün, Gonca Alak, et al.. (2021). Biological activities of a newly synthesized pyrazoline derivative 4-(3-(4-bromophenyl)-5-(2,4-dimethoxyphenyl)-4,5-dihydro-1H-pyrazol-1-yl) benzenesulfonamide (B4) compound on rainbow trout alevins, Oncorhynchus mykiss. In Vitro Cellular & Developmental Biology - Animal. 57(1). 17–20. 2 indexed citations
2.
Yamalı, Cem, Mehtap Tugrak, Dilan Özmen Özgün, et al.. (2020). Phenothiazine‐based chalcones as potential dual‐target inhibitors toward cholinesterases (AChE, BuChE) and monoamine oxidases (MAO‐A, MAO‐B). Journal of Heterocyclic Chemistry. 58(1). 161–171. 20 indexed citations
4.
Özgün, Dilan Özmen, Halise İnci Gül, Cem Yamalı, et al.. (2018). Synthesis and bioactivities of pyrazoline benzensulfonamides as carbonic anhydrase and acetylcholinesterase inhibitors with low cytotoxicity. Bioorganic Chemistry. 84. 511–517. 134 indexed citations
5.
Gül, Halise İnci, Cem Yamalı, Hiroshi Sakagami, et al.. (2018). New anticancer drug candidates sulfonamides as selective hCA IX or hCA XII inhibitors. Bioorganic Chemistry. 77. 411–419. 117 indexed citations
6.
Bozkurt, Ebru, Halise İnci Gül, & Dilan Özmen Özgün. (2018). Pyrazoline derived new “off-on-off” fluorescent pH sensors. Optical Materials. 84. 550–555. 14 indexed citations
7.
Yamalı, Cem, Dilan Özmen Özgün, Halise İnci Gül, et al.. (2017). Synthesis and structure elucidation of 1-(2,5/3,5-difluorophenyl)-3-(2,3/2,4/2,5/3,4-dimethoxyphenyl)-2-propen-1-ones as anticancer agents. Medicinal Chemistry Research. 26(9). 2015–2023. 21 indexed citations
8.
Yamalı, Cem, Halise İnci Gül, Dilan Özmen Özgün, et al.. (2017). Synthesis and Cytotoxic Activities of Difluoro-Dimethoxy Chalcones. Anti-Cancer Agents in Medicinal Chemistry. 17(10). 1426–1433. 22 indexed citations
9.
Özgün, Dilan Özmen, Cem Yamalı, Halise İnci Gül, et al.. (2016). Inhibitory effects of isatin Mannich bases on carbonic anhydrases, acetylcholinesterase, and butyrylcholinesterase. Journal of Enzyme Inhibition and Medicinal Chemistry. 31(6). 1498–1501. 134 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026